BENEFITING: EMILY WHITEHEAD FOUNDATION
EVENT DATE: Nov 18, 2017
Emily Whitehead is a 3-time leukemia survivor. She was the first child in the world to receive a breakthrough T-cell immunotherapy to finally beat her leukemia. Emily is alive today because of cancer research. We saw firsthand how cancer research is saving lives; however, there are still children losing their lives every day because of limited treatment options for high-risk patients like Emily. Children who have their cancer return are harder to treat because their cancer becomes resistant to standard therapies. Cutting edge treatments like the T-cell therapy are needed to help cure these children but funding is limited. Childhood cancer receives only 4% of the National Cancer Institute budget for research. Many researchers rely on grants from non-profit organizations and private donors who are dedicated to raising funds for childhood cancer research.
Please visit www.emilywhiteheadfoundation.org for more info on our efforts to find a cure for childhood cancer!